Recent Updates
Recently added Catalysts
IONS

Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit

Key Takeaway: Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit

Full Press Release Details

Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit.
Last updated: Sep 28, 2023